MRNA241213C30000
- 13.05
- 0.000.00%
Moderna Newsroom
MicroStrategy Shares Could Surge Even Higher If Added to Nasdaq 100 on Friday, Crypto Analyst Says
Moderna Options Spot-On: On December 11th, 68,962 Contracts Were Traded, With 700.56K Open Interest
Super Micro Computer Teeters On Edge Of Nasdaq 100: Can XAI, Nvidia Help Stabilize Trajectory?
Unusual Options Activity: ACI, FTI and Others Attract Market Bets, ACI V/OI Ratio Reaches 75.0
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Moderna Reinstated With an Underperform at BofA
BofA Securities Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $41
BofA Downgrades Moderna, Says It's 'Tough Time' to Be Vaccine Maker
BofA Restarts Coverage of 11 Large-cap Biopharmas
Moderna Options Spot-On: On December 10th, 84,390 Contracts Were Traded, With 683.81K Open Interest
Market Falls Wednesday, but Googles Chip Impresses | WST
FDA Highlights Safety Challenges And Development Needs For Pediatric RSV Vaccines Amid Historical Concerns And Recent MRNA Trial Pauses; Focus On Addressing Unmet Needs For Infants And Toddlers.
Express News | FDA Highlights Safety Challenges And Development Needs For Pediatric RSV Vaccines Amid Historical Concerns And Recent MRNA Trial Pauses; Focus On Addressing Unmet Needs For Infants And Toddlers
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
Unpacking the Latest Options Trading Trends in Moderna
Expert Outlook: Moderna Through The Eyes Of 19 Analysts
Express News | B of A Securities Reinstates Underperform on Moderna, Announces $41 Price Target
Moderna Analyst Ratings
Moderna Options Spot-On: On December 9th, 95,926 Contracts Were Traded, With 711.04K Open Interest
Monday Market Falls, Chinese Stocks Climb, Indices Rebalance | Live Stock